These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28000783)

  • 1. Illegitimate translation causes unexpected gene expression from on-target out-of-frame alleles created by CRISPR-Cas9.
    Makino S; Fukumura R; Gondo Y
    Sci Rep; 2016 Dec; 6():39608. PubMed ID: 28000783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a GLI3 compound heterozygous knockout human embryonic stem cell line WAe001-A-20 by CRISPR/Cas9 editing.
    Wei R; Yuan F; Wu Y; Liu Y; You K; Yang Z; Chen Y; Getachew A; Wang N; Xu Y; Zhuang Y; Yang F; Li YX
    Stem Cell Res; 2018 Oct; 32():139-144. PubMed ID: 30278376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does.
    Petrezselyova S; Kinsky S; Truban D; Sedlacek R; Burtscher I; Lickert H
    Cell Mol Biol Lett; 2015 Dec; 20(5):773-87. PubMed ID: 26540224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of CRISPR-Cas9 on target identification and validation.
    Moore JD
    Drug Discov Today; 2015 Apr; 20(4):450-7. PubMed ID: 25572406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinjection-based generation of mutant mice with a double mutation and a 0.5 Mb deletion in their genome by the CRISPR/Cas9 system.
    Hara S; Kato T; Goto Y; Kubota S; Tamano M; Terao M; Takada S
    J Reprod Dev; 2016 Oct; 62(5):531-536. PubMed ID: 27396308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cellular mRNAs translation by CRISPR-Cas9.
    Liu Y; Chen Z; He A; Zhan Y; Li J; Liu L; Wu H; Zhuang C; Lin J; Zhang Q; Huang W
    Sci Rep; 2016 Jul; 6():29652. PubMed ID: 27405721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant genome engineering in full bloom.
    Lozano-Juste J; Cutler SR
    Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations.
    Kuscu C; Parlak M; Tufan T; Yang J; Szlachta K; Wei X; Mammadov R; Adli M
    Nat Methods; 2017 Jul; 14(7):710-712. PubMed ID: 28581493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
    Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
    Alagoz Y; Gurkok T; Zhang B; Unver T
    Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells.
    Reber S; Mechtersheimer J; Nasif S; Benitez JA; Colombo M; Domanski M; Jutzi D; Hedlund E; Ruepp MD
    Mol Biol Cell; 2018 Jan; 29(2):75-83. PubMed ID: 29167381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Genome Editing in Chicken DF-1 Cells Using the CRISPR/Cas9 System.
    Bai Y; He L; Li P; Xu K; Shao S; Ren C; Liu Z; Wei Z; Zhang Z
    G3 (Bethesda); 2016 Apr; 6(4):917-23. PubMed ID: 26869617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
    Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
    J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
    Auer TO; Del Bene F
    Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.